Back
MiMedx Group Vs. Amylyx Pharmaceuticals Industry Stock Comparison
Buy
63
MDXG
MiMedx Group
Last Price:
7.88
Seasonality Move:
16.63%
Sell
26
AMLX
Amylyx Pharmaceuticals
Last Price:
1.84
Seasonality Move:
101.62%
Buy
63
MiMedx Group (MDXG)
is a Buy
Is MiMedx Group a Buy, Sell or Hold?
- The current MiMedx Group [MDXG] share price is $8.08. The Score for MDXG is 63, which is 26% above its historic median score of 50, and infers lower risk than normal.
- MDXG is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
26
Amylyx Pharmaceuticals (AMLX)
is a Sell
Is Amylyx Pharmaceuticals a Buy, Sell or Hold?
- The current Amylyx Pharmaceuticals [AMLX] share price is $1.82. The Score for AMLX is 26, which is 48% below its historic median score of 50, and infers higher risk than normal.
- AMLX is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
MDXG Stock Price Chart
What is MiMedx Group's stock price today?
-
The MiMedx Group share price today is $8.08
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and MDXG is experiencing buying pressure, which is a positive indicator for future bullish movement.
AMLX Stock Price Chart
What is Amylyx Pharmaceuticals's stock price today?
-
The Amylyx Pharmaceuticals share price today is $1.82
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and AMLX is experiencing selling pressure, which indicates risk of future bearish movement.
MDXG Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.23 | Buy |
| Relative Strength Index (14 RSI): | 68.65 | Buy |
| Chaikin Money Flow: | 627696 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (6.23 - 7.45) | Buy |
| Bollinger Bands (100): | (6.99 - 8.43) | Buy |
AMLX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.5 | Sell |
| Relative Strength Index (14 RSI): | 29.25 | Sell |
| Chaikin Money Flow: | -1095885 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (1.81 - 2.05) | Sell |
| Bollinger Bands (100): | (2.59 - 16.49) | Sell |
MDXG Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 7.52 | Buy |
| 20-day SMA: | 6.95 | Buy |
| 50-day SMA: | 7.24 | Buy |
| 200-day SMA: | 7.52 | Buy |
| 8-day EMA: | 7.6 | Buy |
| 20-day EMA: | 7.23 | Buy |
| 50-day EMA: | 7.26 | Buy |
| 200-day EMA: | 7.17 | Buy |
AMLX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 1.88 | Sell |
| 20-day SMA: | 1.9 | Sell |
| 50-day SMA: | 3.07 | Sell |
| 200-day SMA: | 13.6 | Sell |
| 8-day EMA: | 1.86 | Sell |
| 20-day EMA: | 2.09 | Sell |
| 50-day EMA: | 4.27 | Sell |
| 200-day EMA: | 12.6 | Sell |
MiMedx Group Earnings Growth & MDXG Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.03 per share, an increase next quarter of $0.01 per share, an increase this year of $0.23 per share, and an increase next year of $0.03 per share.
Amylyx Pharmaceuticals Earnings Growth & AMLX Earnings Dates
- Analysts estimate an earnings decrease this quarter of $1.01 per share, an increase next quarter of $0.14 per share, a decrease this year of $2.19 per share, and a decrease next year of $0.28 per share.
MiMedx Group Technical Analysis
| May 2 | May 3 | May 6 | May 7 | May 8 | May 9 | May 10 | May 13 | May 14 | May 15 | |
|---|---|---|---|---|---|---|---|---|---|---|
| May | ||||||||||
| 02 | 03 | 06 | 07 | 08 | 09 | 10 | 13 | 14 | 15 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Amylyx Pharmaceuticals Technical Analysis
| May 2 | May 3 | May 6 | May 7 | May 8 | May 9 | May 10 | May 13 | May 14 | May 15 | |
|---|---|---|---|---|---|---|---|---|---|---|
| May | ||||||||||
| 02 | 03 | 06 | 07 | 08 | 09 | 10 | 13 | 14 | 15 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||